Clinical trial

Comparison of Antiemetic Drugs in Preventing Delayed Nausea After Chemotherapy…

NCT00020657 · Gary Morrow, Other · Completed

Key facts

NCT number NCT00020657
Title Comparison of Antiemetic Drugs in Preventing Delayed Nausea After Chemotherapy in Patients With Cancer
Official title Treatment of Delayed Nausea: What Works Best?
Lead sponsor Gary Morrow, Other
Collaborators National Cancer Institute (NCI) NIH
Status Completed
Phase Phase 3
Study type Interventional
Conditions Nausea and Vomiting, Unspecified Adult Solid Tumor, Protocol Specific
Intervention type Drug, Procedure
Interventions dolasetron mesylate, granisetron hydrochloride, ondansetron, prochlorperazine, quality-of-life assessment
Start date Jul 1, 2001
Primary completion Oct 1, 2004
Completion Oct 1, 2004
First posted Jan 27, 2003
Last update posted Oct 15, 2015
Countries United States

At a glance

  • 10–99 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies